# Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

> **NCT06014801** · PHASE2,PHASE3 · RECRUITING · sponsor: **Jikei University School of Medicine** · enrollment: 400 (estimated)

## Conditions studied

- Acute Kidney Injury Requiring Continuous Renal Replacement Therapy

## Interventions

- **DRUG:** Dialysate fluid, Filtration replacement fluid

## Key facts

- **NCT ID:** NCT06014801
- **Lead sponsor:** Jikei University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-30
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014801, "Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06014801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*